Response of Therapy in Cell-Cycle Regulatory Genes in Breast Cancer-Reference-Cited by-同舟云学术

Response of Therapy in Cell-Cycle Regulatory Genes in Breast Cancer

Published:2023 Issue: Volume: Page:335-353
ISSN:
Container-title:Therapeutic potential of Cell Cycle Kinases in Breast Cancer
language:
Short-container-title:

Author:

Mir Manzoor Ahmad^ORCID,Aisha Shariqa,Fatima Kaneez,Malik Fayaz Ahmad

Publisher

Springer Nature Singapore

Link

https://link.springer.com/content/pdf/10.1007/978-981-19-8911-7_16

Reference101 articles.

1. Agus DB et al (2002) Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. Cancer Cell 2(2):127–137

2. Albanell J et al (2004) Phase I study of bortezomib in combination with docetaxel in anthracycline-pretreated advanced breast cancer. In: Proteasome inhibitors in cancer therapy, pp 271–282. https://doi.org/10.1007/978-1-59259-794-9_20

3. Baselga J et al (1996) Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol 14(3):737–744

4. Bedard PL et al (2016) Abstract CT066: first-in-human phase I trial of the oral PLK4 inhibitor CFI-400945 in patients with advanced solid tumors. AACR

5. Bianchini G et al (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13(11):674–690

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Cancer Stem Cells in Drug Resistance;Drug Resistance in Cancer: Mechanisms and Strategies;2024

2. Mechanisms of Cancer Resistance to Various Therapies;Drug Resistance in Cancer: Mechanisms and Strategies;2024

3. Introduction to Drug Resistance in Cancer;Drug Resistance in Cancer: Mechanisms and Strategies;2024